共 50 条
Clopidogrel in ST-elevation myocardial infarction
被引:5
|作者:
Sabatine, Marc S.
机构:
[1] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Thrombolysis Myocardial Infarct TIMI Study Grp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词:
clopidogrel;
fibrinolysis;
ST-elevation myocardial infarction;
D O I:
10.1093/eurheartj/sul052
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Platelet adhesion, activation, and aggregation are central to the pathophysiology of the acute coronary syndromes (ACS). Clopidogrel, an oral thienopyridine derivative, is a platelet adenosine diphosphate (ADP)-receptor antagonist capable of inhibiting platelet activation. The benefits of clopidogrel in patients with stable coronary artery disease undergoing elective percutaneous coronary interventions (PCI) and in patients presenting with non-ST-elevation ACS are well established. This article will review the results of recent clinical trials in which the utility of clopidogrel in patients with ST-elevation myocardial infarction was evaluated.
引用
收藏
页码:G31 / G34
页数:4
相关论文